Skip to main content
Equibles

Rami Levin

Board Member

CNS Pharmaceuticals, Inc. (CNSP)

CEO

CNS Pharmaceuticals, Inc. (CNSP)

Equibles does not estimate personal net worth.

Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get CNSP alerts

About Rami Levin

Rami Levin is recorded as Board Member and CEO at CNS Pharmaceuticals, Inc. (CNSP) since January 1, 2026. The newest filing on record that lists Rami Levin as Board Member and CEO at CNS Pharmaceuticals, Inc. (CNSP) is dated August 21, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed October 2, 2026 that Rami Levin was appointed director, effective September 30, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed December 17, 2025 that Rami Levin was appointed member of the Company's Board of Directors, effective January 1, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed December 17, 2025 that Rami Levin was appointed Chief Executive Officer and President, effective January 1, 2026. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Faith Charles (Chairman and Board Member), Steve O'Loughlin (CFO), Eric Faulkner (CTO) and 7 others.

“The Company's stockholders elected Faith Charles, Bettina Cockroft, Michal Fisher, Jeffrey Keyes, Rami Levin and Amy Mahery, as directors of the Company until the Company's 2027 Annual Meeting of Stockholders, or until their respective successors have been duly elected and qualified, by the following vote:”
CNS Pharmaceuticals, Inc. Form 8-K, filed October 2, 2026 · Read the filing
“On December 16, 2025, the Board of Directors agreed to appoint Mr. Levin as a member of the Company's Board of Directors as of January 1, 2026.”
CNS Pharmaceuticals, Inc. Form 8-K, filed December 17, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CNS Pharmaceuticals, Inc.

Recent activity